MycoTechnology has partnered with brands to deliver foods, beverages, and supplements by harnessing the metabolic engine of mushrooms to create novel ingredients. The Colorado-based functional ingredients platform leverages a proprietary mushroom fermentation...
The potential benefits of mulberry fruit extracts to reduce blood sugar and insulin increases after a meal may be achievable at a lower dose than previously reported, says a new study from Unilever R&D.
One of the UK’s biggest white label manufacturers, purely dedicated to CBD, believes the publication of the Food Standard’s Agency list will leave the market with a “pool of very vanilla products” and says it’s frustrating after the industry has moved...
In the latest in our series profiling this year’s Award contenders, NutraIngredients talks to Michael Wakeman, founder of Vitmedics, whose innovation Vitcheck is up for this year’s Personalised Nutrition Award.
Netherlands-based NutriLeads has received a letter of no objection from the US Food and Drug Administration (FDA) regarding the Generally Recognized as Safe (GRAS) status of its upcycled immune health ingredient, BeniCaros.
Swisse has recently entered the Sri Lankan market, highlighting that it is “a market that has always punched above its weight”, despite the country facing one of its worst economic and political crises.
Researchers have found evidence of a reduced risk of bladder cancer associated with tea drinking and report that it was significant among men and former smokers but not among women and those who had never smoked.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
A doctor diagnosed with multiple sclerosis 20 years ago at the age of 16, is so determined to help others with health issues he has carved a career in research, created a company and recently launched two products that promote immune health.
NutraIngredients took the opportunity to speak to Magali Cordaillat-Simmons, Scientific and Regulatory Affairs Director, Pharmabiotic Research Institute (PRI) on regulatory science and how it paves the way for innovative therapies.
A standard milk-based therapy fortified with a specific strain of gut bacteria may reduce inflammation in the infant gut and promote weight gain in infants with severe acute malnutrition, says a new study.
With an ever-expanding portfolio, Kerry Taste & Nutrition is looking to expand its ingredients into new formats, with its new liquid BC30 probiotic giving opportunities in plant-based milks and liquid milk.
Bonafide, a company focused on healthcare products for women, has acquired the rights to an enhanced S-adenosylmethionine (SAM-e) formulation. The company said the acquisition means it now has more than 50 issued or pending patents that it owns or has...
Enzymit, an Israeli development state company, has secured $5 million in funding to further develop its AI platform that can greatly speed the development of novel enzymes. The technology has the potential to cut the cost of many ingredients now made...
Interest in the human microbiome has never been higher, but much of the attention to date has focused on bacteria, with much less research dedicated to fungi (the mycobiome) and viruses called bacteriophages (known as the virome or phageome).